$258.28+$5.06 (+2.0%)
International Business Machines Corporation’s quoted price sits in the lower half of its reported 52-week range, 22.31% below the high.
Loading market information…
NASDAQ · CTSH · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Cognizant Technology Solutions Corporation’s quoted price sits in the upper half of its reported 52-week range, 28.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Cognizant Technology Solutions Corporation’s forward annual dividend is $1.32 per share, paid quarterly. The forward yield is 2.11% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Cognizant Technology Solutions Corporation’s next earnings report is currently expected on Feb 10, 2027, with estimated earnings per share of $1.53. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Cognizant Technology Solutions Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 29, 2026, 09:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| $5.42B+1.82% vs estimate |
| Q2 2025 | Jul 30, 2025 | $1.31+3.97% vs estimate | $5.25B+1.11% vs estimate |
|---|
| Q1 2025 | Apr 30, 2025 | $1.23+2.5% vs estimate | $5.12B+1.01% vs estimate |
|---|
| Q4 2024 | Feb 5, 2025 | $1.21+8.04% vs estimate | $5.08B+0.23% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
51 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 12 contributors · Median target $66.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$258.28+$5.06 (+2.0%)
International Business Machines Corporation’s quoted price sits in the lower half of its reported 52-week range, 22.31% below the high.
$247.22+$3.82 (+1.57%)
Accenture plc’s quoted price sits in the upper half of its reported 52-week range, 15.07% below the high.
₹2,478.00+₹18.00 (+0.73%)
Tata Consultancy Services Limited’s quoted price sits in the lower half of its reported 52-week range, 26.03% below the high.
$12.20+$0.11 (+0.91%)
Infosys Limited’s quoted price sits in the lower half of its reported 52-week range, 59.33% below the high.
₹1,403.90+₹3.40 (+0.24%)
HCL Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 21.13% below the high.
$2.11+$0.05 (+2.43%)
Wipro Limited’s quoted price sits in the lower half of its reported 52-week range, 31.72% below the high.
₹1,769.60-₹7.00 (-0.39%)
Tech Mahindra Limited’s quoted price sits in the upper half of its reported 52-week range, 4.55% below the high.
$79.59+$0.27 (+0.34%)
CGI Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.4% below the high.
